Lipid-based microemulsion gel for the topical delivery of methotrexate: an optimized, rheologically acceptable formulation with conducive dermatokinetics-Reference-Cited by-同舟云学术

Lipid-based microemulsion gel for the topical delivery of methotrexate: an optimized, rheologically acceptable formulation with conducive dermatokinetics

Published:2024-06-01 Issue:6 Volume:316 Page:
ISSN:1432-069X
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Mishra Mohini,Barkat Md. Abul,Misra Charu,Alanezi Abdulkareem Ali,Ali Amena,Chaurawal Nishtha,Ali Abuzer,Preet Simran,Barkat Harshita,Raza Kaisar

Funder

Taif University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00403-024-03140-8.pdf

Reference33 articles.

1. Boni FI, Almeida A, Lechanteur A, Sarmento B, Cury BSF, Gremião MPD (2018) Mucoadhesive nanostructured polyelectrolytes complexes modulate the intestinal permeability of methotrexate. Eur J Pharm Sci 111:73–82. https://doi.org/10.1016/J.EJPS.2017.09.042

2. Giri BR, Kim JS, Park JH, Jin SG, Kim KS, Ud Din F, Choi HG, Kim DW (2021) Improved bioavailability and high photostability of methotrexate by spray-dried surface-attached solid dispersion with an aqueous medium. Pharmaceutics 13:1–14. https://doi.org/10.3390/PHARMACEUTICS13010111

3. Rajalingam K, Krishnaswami V, Alagarsamy S, Kandasamy R (2021) Solubility enhancement of methotrexate by solid nanodispersion approach for the improved treatment of small cell lung carcinoma. Curr Top Med Chem 21:140–150. https://doi.org/10.2174/1568026620999200904120241

4. Yu W-J, Huang D-X, Liu S, Sha Y-L, Gao F, Liu H (2020) Polymeric nanoscale drug carriers mediate the delivery of methotrexate for developing therapeutic interventions against cancer and rheumatoid arthritis. Front Oncol 10:1734. https://doi.org/10.3389/fonc.2020.01734

5. Amarji B, Garg NK, Singh B, Katare OP (2016) Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics. J Drug Target 24:147–160. https://doi.org/10.3109/1061186X.2015.1058804